Health Care & Life Sciences » Biotechnology | Genscript Biotech Corp.

Genscript Biotech Corp. | Income Statement

Fiscal year is January-December. All values HKD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
466
543
672
891
1,190
1,811
Cost of Goods Sold (COGS) incl. D&A
177
210
231
301
377
580
Gross Income
290
333
441
590
812
1,230
SG&A Expense
218
271
316
396
447
1,198
EBIT
69
59
125
194
366
32
Unusual Expense
-
-
25
-
8
10
Non Operating Income/Expense
6
1
22
45
113
59
Interest Expense
-
5
7
-
-
-
Pretax Income
58
61
178
252
300
179
Income Tax
12
13
42
46
90
15
Equity in Affiliates
-
-
-
-
-
2
Consolidated Net Income
47
48
136
206
210
163
Net Income
47
48
136
203
204
166
Net Income After Extraordinaries
47
48
136
203
204
166
Net Income Available to Common
47
48
136
203
204
166
EPS (Basic)
0.03
0.03
0.11
0.12
0.12
0.09
Basic Shares Outstanding
1,600
1,600
1,193
1,667
1,714
1,792
EPS (Diluted)
0.03
0.03
0.11
0.12
0.12
0.09
Diluted Shares Outstanding
1,600
1,600
1,228
1,709
1,729
1,840
EBITDA
104
96
163
234
419
132
Other Operating Expense
3
3
-
-
-
-
Non-Operating Interest Income
-
1
2
2
7
78
Minority Interest Expense
-
-
-
3
7
4

About Genscript Biotech

View Profile
Address
No. 28, Yongxi Road
Nanjing Jiangsu 210000
China
Employees -
Website http://www.genscript.com
Updated 07/08/2019
Genscript Biotech Corp. is a holding company, which engages in the manufacture and sale of life sciences research products and services. It operates through the following segments: Bio-science Services and Products; Precision Immune-cell Therapy; and Industrial Synthetic Biology Products. The Bio-science Services and Products segment includes life sciences research services, life sciences research catalogue products, and preclinical drug development services.